Case Report

Insulin-like growth factor-1 receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell carcinoma†

  1. Christine H. Chung MD1,2,*,
  2. Paula R. Pohlmann MD, PhD1,
  3. Mace L. Rothenberg MD1,
  4. Brian B. Burkey MD3,
  5. Joel Parker MS4,
  6. Kevin Palka MD1,
  7. Joseph Aulino MD5,
  8. Igor Puzanov MD1,
  9. Barbara Murphy MD1

Article first published online: 22 JUL 2010

DOI: 10.1002/hed.21478

Issue

Head & Neck

Head & Neck

Volume 33, Issue 12, pages 1804–1808, December 2011

Additional Information

How to Cite

Chung, C. H., Pohlmann, P. R., Rothenberg, M. L., Burkey, B. B., Parker, J., Palka, K., Aulino, J., Puzanov, I., Murphy, B. (2011), Insulin-like growth factor-1 receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell carcinoma. Head Neck, 33: 1804–1808. doi: 10.1002/hed.21478

Author Information

  1. 1

    Division of Hematology/Oncology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee

  2. 2

    Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee

  3. 3

    Department of Otolaryngology, Cleveland Clinic, Cleveland, Ohio

  4. 4

    Expression Analysis, Durham, North Carolina

  5. 5

    Department of Radiology, Vanderbilt University School of Medicine, Nashville, Tennessee

*Division of Hematology/Oncology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee

  1. †

    Conflict of interest statement: Dr. Chung served on a paid advisory board for Bristol-Myers-Squibb and received honorarium from Amgen for an educational lecture. Dr. Rothenberg serves as a consultant for ImClone, Bristol Myers-Squibb, and Amgen.

Publication History

  1. Issue published online: 11 NOV 2011
  2. Article first published online: 22 JUL 2010
  3. Manuscript Accepted: 7 APR 2010

Funded by

  • Damon Runyon Clinical Investigator Award. Grant Numbers: (CI-28-05), 1 RO1 DE017982-01

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (751K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • If you would like institutional access to this content, please recommend the title to your librarian.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

If your institution is a registered Wiley Online Library customer, you can log in under your institution's name to see our content. This access is provided by Shibboleth or Athens.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

View Full Article with Supporting Information (HTML) Get PDF (751K)